Literature DB >> 28011705

Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research.

Marius M Hoeper1, Carolyn S P Lam2, Jean-Luc Vachiery3, Johann Bauersachs4, Christian Gerges5, Irene M Lang5, Diana Bonderman5, Karen M Olsson1, J Simon R Gibbs6, Peter Dorfmuller7, Marco Guazzi8, Nazzareno Galiè9, Alessandra Manes9, M Louis Handoko10, Anton Vonk-Noordegraaf11, Mareike Lankeit12, Stavros Konstantinides13, Rolf Wachter14, Christian Opitz15, Stephan Rosenkranz16.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28011705     DOI： 10.1093/eurheartj/ehw597

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  29 in total

Review 1.  Novel Insights and Treatment Strategies for Right Heart Failure.

Authors:  Weiqin Lin; Ai-Ling Poh; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2018-06

2.  Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Authors:  Barry A Borlaug; Masaru Obokata
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983

3.  Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.

Authors:  Thomas M Gorter; Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Barry A Borlaug
Journal:  Eur Heart J       Date:  2018-08-07       Impact factor: 29.983

4.  The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Katlyn E Koepp; Alexander C Egbe; Brandon Wiley; Barry A Borlaug
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

5.  Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Authors:  Jason M Elinoff; Richa Agarwal; Christopher F Barnett; Raymond L Benza; Michael J Cuttica; Ahmed M Gharib; Michael P Gray; Paul M Hassoun; Anna R Hemnes; Marc Humbert; Todd M Kolb; Tim Lahm; Jane A Leopold; Stephen C Mathai; Vallerie V McLaughlin; Ioana R Preston; Erika B Rosenzweig; Oksana A Shlobin; Virginia D Steen; Roham T Zamanian; Michael A Solomon
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

6.  The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

Authors:  Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Vojtech Melenovsky; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

7.  Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.

Authors:  Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Sorin Pislaru; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-02-21       Impact factor: 29.983

Review 8.  Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).

Authors:  Carsten Tschöpe; Christoph Birner; Michael Böhm; Oliver Bruder; Stefan Frantz; Andreas Luchner; Lars Maier; Stefan Störk; Behrouz Kherad; Ulrich Laufs
Journal:  Clin Res Cardiol       Date:  2017-10-10       Impact factor: 5.460

9.  Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis.

Authors:  Charles-Antoine Guay; Louis-Vincent Morin-Thibault; Sebastien Bonnet; Yves Lacasse; Caroline Lambert; Jean-Christophe Lega; Steeve Provencher
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

Review 10.  Evaluation and management of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.